Philip Morris v. RAI Strategic Holdings: Federal Circuit Affirms Smoking Article Patent
Philip Morris Products, SA and RAI Strategic Holdings, Inc. clashed at the Federal Circuit over the validity of US9901123B2, protecting a tobacco-containing smoking article. The court issued a clean affirmance, leaving the patent intact after 471 days of appellate proceedings.
Federal Circuit closes RAI's challenge to Philip Morris smoking article patent
Philip Morris Products, SA — the Swiss arm of the Philip Morris International group — brought this appeal before the Court of Appeals for the Federal Circuit (Case No. 22-1846), filed 31 May 2022. The case centres on US9901123B2, a patent covering a tobacco-containing smoking article, which RAI Strategic Holdings, Inc. had challenged through an invalidity/cancellation action at the underlying tribunal. RAI Strategic Holdings is the IP holding entity of Reynolds American, a major competitor in the tobacco and next-generation nicotine-product sector.
The Federal Circuit issued its order on 14 September 2023, affirming the decision below in a single dispositive line: 'AFFIRMED.' The recorded basis of termination is 'Patent Upheld,' consistent with an affirmance of a patentability ruling that found US9901123B2 valid and enforceable. For Philip Morris, the outcome preserves the patent as an active enforcement asset. For RAI, the appellate avenue to cancel this patent is exhausted at this court level.
The 471-day duration is consistent with a standard Federal Circuit briefing and decision cycle for patent validity appeals. The terse order suggests the panel found no reversible error warranting extended analysis. The specific grounds on which the lower tribunal upheld the patent, and the precise invalidity arguments RAI advanced, are not detailed in the available public docket record for this appellate proceeding.
See Complete Case & Patent Analysis →Filing to Patent Upheld in 471 days
471 days from filing to Federal Circuit decision — a moderately fast appellate resolution.
US9901123B2 — tobacco-containing smoking article
Any R&D or product team active in tobacco-containing smoking articles — including heated tobacco devices, alternative delivery formats, or novel tobacco rod constructions — should treat US9901123B2 as a high-priority FTO asset following the Federal Circuit's affirmance. The patent has now survived adversarial invalidity scrutiny, meaning the risk profile for competitors operating near its claim scope has materially increased. This is particularly relevant for companies that may have been monitoring the case outcome before finalising product designs or market-entry plans.
Official order — verbatim text
The Federal Circuit's order — 'THIS CAUSE having been considered, it is ORDERED AND ADJUDGED: AFFIRMED' — is a merits affirmance of the patentability decision below. The terseness of the order is consistent with a non-precedential or Rule 36 affirmance, meaning the panel determined the lower tribunal's reasoning required no elaboration or correction. The substantive validity of US9901123B2 is thereby confirmed at the appellate level, and the basis of termination is recorded as 'Patent Upheld.'
Federal Circuit affirms: what the ruling means for both parties
What 'AFFIRMED' means at the Federal Circuit
An affirmance by the Federal Circuit means the appellate panel reviewed the lower tribunal's patentability decision and found no reversible error — whether on claim construction, obviousness, anticipation, or procedural grounds. The lower decision stands in full. The Federal Circuit does not retry the case; it reviews for legal error and, on factual findings, for clear error or substantial evidence.
No reversible error foundPhilip Morris: patent survives and remains enforceable
For Philip Morris Products, the affirmance confirms that US9901123B2 is valid and enforceable. A Federal Circuit affirmance carries significant precedential weight: any future challenger faces the same prior-art and validity arguments already tested and rejected. Philip Morris can now enforce the patent with greater confidence, including in infringement actions against RAI or third parties, for the remaining term of the patent.
Patent enforceability confirmedRAI's appellate options exhausted at this level
RAI Strategic Holdings' invalidity/cancellation challenge has been rejected. With the Federal Circuit having affirmed, RAI's options at this court level are exhausted. A petition for rehearing en banc or a certiorari petition to the Supreme Court would be the only remaining avenues, each carrying a very high bar. RAI may not re-litigate the same invalidity grounds in a new proceeding where estoppel applies.
Challenge rejected on appealStrengthened patent raises the bar for heated tobacco IP challengers
A Federal Circuit affirmance of a tobacco smoking article patent raises the strategic cost for competitors seeking to design around or challenge related Philip Morris IP. Companies active in heated tobacco and next-generation nicotine products should assess their own product designs against the claims of US9901123B2. The ruling also signals that Philip Morris's prosecution strategy for this patent family is holding up under adversarial scrutiny.
Higher bar for future challengesFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Philip Morris Products, SA | Company | /Search in Eureka ↗ |
| Defendant | Rai Strategic Holdings, Inc. | Company | /Search in Eureka ↗ |
| Plaintiff counsel | David Zucker | Attorney | Counsel for Philip Morris Products, SASearch in Eureka ↗ |
| Plaintiff counsel | Gabriel K. Bell | Attorney | Counsel for Philip Morris Products, SASearch in Eureka ↗ |
| Plaintiff counsel | Gregory Sobolski | Attorney | Counsel for Philip Morris Products, SASearch in Eureka ↗ |
| Plaintiff counsel | Jonathan M. Strang | Attorney | Counsel for Philip Morris Products, SASearch in Eureka ↗ |
| Plaintiff counsel | Maximilian A. Grant | Attorney | Counsel for Philip Morris Products, SASearch in Eureka ↗ |
| Plaintiff counsel | Takashi Okuda | Attorney | Counsel for Philip Morris Products, SASearch in Eureka ↗ |
| Plaintiff law firm | Latham & Watkins, LLP | Law Firm | Representing Philip Morris Products, SASearch in Eureka ↗ |
| Defendant counsel | Amelia A. DeGory | Attorney | Counsel for Rai Strategic Holdings, Inc.Search in Eureka ↗ |
| Defendant counsel | David B. Cochran | Attorney | Counsel for Rai Strategic Holdings, Inc.Search in Eureka ↗ |
| Defendant counsel | David Michael Maiorana | Attorney | Counsel for Rai Strategic Holdings, Inc.Search in Eureka ↗ |
| Defendant counsel | Gregory A. Castanias | Attorney | Counsel for Rai Strategic Holdings, Inc.Search in Eureka ↗ |
| Defendant counsel | Joshua R. Nightingale | Attorney | Counsel for Rai Strategic Holdings, Inc.Search in Eureka ↗ |
| Defendant counsel | Kenneth Luchesi | Attorney | Counsel for Rai Strategic Holdings, Inc.Search in Eureka ↗ |
| Defendant counsel | Robert Breetz | Attorney | Counsel for Rai Strategic Holdings, Inc.Search in Eureka ↗ |
| Defendant law firm | Jones Day | Law Firm | Representing Rai Strategic Holdings, Inc.Search in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Court of Appeals for the Federal CircuitSearch in Eureka ↗ |
R&D signals in the tobacco and smoking article IP space
Forward-looking patent and innovation intelligence derived from Philip Morris v. RAI — covering filing trends, white space, and competitive IP posture in heated tobacco and smoking article technology.
Philip Morris's smoking article patent estate beyond US9901123B2
US9901123B2 is one patent within what is believed to be a broad Philip Morris International filing programme in next-generation tobacco and smoking article technology. R&D teams should map the continuation and PCT family surrounding US15/286087 to understand the full claim perimeter Philip Morris is defending — and where enforcement activity may expand next.
Philip Morris IP portfolioFiling trends in tobacco-containing smoking article innovations
The tobacco-containing smoking article domain — covering both conventional and heated formats — is an area of sustained patent filing activity by major players including Philip Morris, RAI/Reynolds American, Japan Tobacco, and British American Tobacco. Tracking CPC subclass A24D and A24B filing trends reveals where R&D investment is concentrating and where design-around white space may exist.
Smoking article filing trendsRAI Strategic Holdings' defensive patent position post-affirmance
RAI Strategic Holdings and Reynolds American maintain their own substantial patent portfolios in tobacco product innovation. Following the Federal Circuit's affirmance against RAI, monitoring RAI's prosecution activity — new filings, continuation applications, and inter partes review petitions — may surface a defensive or offensive IP response to the validated Philip Morris patent.
RAI IP filing activityDesign-around opportunities adjacent to US9901123B2 claims
With US9901123B2 now confirmed valid, identifying claim boundaries and unclaimed adjacent technology is commercially critical for competitors. White-space analysis around tobacco rod construction, filter integration, and aerosol-generating components may reveal engineering pathways that fall outside the confirmed claim scope — relevant for product teams seeking FTO clearance in the US market.
Design-around white spaceSimilar Federal Circuit patent validity appeals in tobacco and smoking technology
Explore comparable Federal Circuit appeals involving tobacco product patents and invalidity/cancellation challenges in the next-generation nicotine and smoking article sector.
What this case signals for the heated tobacco IP landscape
The Federal Circuit's affirmance in Philip Morris v. RAI reinforces the validity of smoking article patents amid intensifying competition in next-generation tobacco products.
US9901123B2 is now a hardened enforcement asset for Philip Morris
Having survived a Federal Circuit validity challenge, US9901123B2 carries stronger presumption of validity in any future infringement action. Competitors and licensees in the tobacco-containing smoking article space should treat this patent as a high-priority FTO risk. The affirmance narrows the window for prior-art-based challenges previously advanced by RAI.
RAI faces estoppel risk on grounds already litigated
Where estoppel applies, RAI Strategic Holdings may be barred from re-raising invalidity arguments that were or could have been raised in this proceeding. Counsel advising RAI or Reynolds American affiliates should map the grounds litigated against current product portfolios and assess residual freedom-to-operate exposure under the confirmed patent claims.
Philip v Rai — key questions answered
The Court of Appeals for the Federal Circuit affirmed the lower patentability decision on 14 September 2023. The recorded basis of termination is 'Patent Upheld,' meaning US9901123B2 — a patent covering a tobacco-containing smoking article — survived RAI Strategic Holdings' invalidity/cancellation challenge. The case ran for 471 days from filing to decision.
The patent at issue is US9901123B2, filed under application number US15/286087. It covers a tobacco-containing smoking article. Philip Morris Products, SA is the patent holder; RAI Strategic Holdings, Inc. — the IP arm of Reynolds American — challenged its validity through an invalidity/cancellation action that ultimately reached the Federal Circuit.
An affirmance confirms that the lower tribunal found no reversible legal error in upholding the patent. US9901123B2 now carries heightened presumption of validity following adversarial appellate scrutiny. Philip Morris can enforce it with greater confidence, while RAI and similarly positioned challengers face a materially higher bar if they seek to re-litigate validity on the same grounds.
The verdict cause is recorded as an invalidity/cancellation action on patentability grounds. The specific invalidity arguments RAI Strategic Holdings advanced — such as anticipation, obviousness, or prior-art references — are not detailed in the available appellate docket record for Case No. 22-1846.
Philip Morris Products, SA was represented by Latham & Watkins, LLP, with attorneys including Maximilian A. Grant, Jonathan M. Strang, Gabriel K. Bell, Gregory Sobolski, David Zucker, and Takashi Okuda. RAI Strategic Holdings, Inc. was represented by Jones Day, with attorneys including Gregory A. Castanias, David B. Cochran, David Michael Maiorana, Amelia A. DeGory, Joshua R. Nightingale, Kenneth Luchesi, and Robert Breetz.
This page is compiled from public court dockets and third-party patent and litigation data via PatSnap Eureka, and is provided for general informational purposes only. The information shown — including party names, patent and application numbers, dates, case status, outcomes, and any analysis — may be incomplete, may not reflect the most recent filings or legal status, and may contain errors or omissions. Verify all details against official court records (for example, PACER) and the relevant patent office before relying on them.
Nothing on this page constitutes legal advice or a legal opinion on the validity, infringement, enforceability, or scope of any patent or case, and no attorney‑client relationship is created by its use. Any description of an outcome (such as a dismissal, settlement, or consent judgment) is a general summary, not a legal determination. All patents, trademarks, and company or law‑firm names are the property of their respective owners. PatSnap makes no warranty as to the accuracy or completeness of this content and disclaims, to the fullest extent permitted by law, all liability for reliance on it. For advice on a specific matter, consult qualified legal counsel.
PatSnap Eureka searches patents and litigation data to answer instantly.